Literature DB >> 6445607

Dose response of ipratropium assessed by two methods.

C J Allen, A H Campbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6445607      PMCID： PMC471239          DOI： 10.1136/thx.35.2.137

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  6 in total

1.  Bronchodilatory and circulatory effects of inhaling increasing doses of an anti-cholinergic drug, ipratropium bromide (SCH 1000).

Authors:  B G Simonsson; B Jonson; B Ström
Journal:  Scand J Respir Dis       Date:  1975-09

2.  VARIATION OF DRUG ACTION ON AIRWAY OBSTRUCTION IN MAN.

Authors:  R E ALTOUNYAN
Journal:  Thorax       Date:  1964-09       Impact factor: 9.139

3.  Ipratropium bromide (Sch 1000) monohydrate aerosol: bronchodilator effect of three dose levels in asthmatics.

Authors:  R E Ruffin; M T Newhouse
Journal:  Lung       Date:  1978       Impact factor: 2.584

4.  Clinical assessment of bronchodilator drugs delivered by aerosol.

Authors:  G M Shenfield; J W Paterson
Journal:  Thorax       Date:  1973-03       Impact factor: 9.139

5.  Bronchodilator action of the anticholinergic drug, ipratropium bromide (Sch 1000), as an aerosol in chronic bronchitis and asthma.

Authors:  W Baigelman; S Chodosh
Journal:  Chest       Date:  1977-03       Impact factor: 9.410

6.  A comparison of the bronchodilator activity of Sch 1000 and salbutamol.

Authors:  R E Ruffin; J D Fitzgerald; A S Rebuck
Journal:  J Allergy Clin Immunol       Date:  1977-02       Impact factor: 10.793
  6 in total
  10 in total

Review 1.  New drugs in respiratory disorders: I.

Authors:  D C Flenley
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-12

Review 2.  Recent advances in respiratory medicine.

Authors:  D C Flenley
Journal:  Postgrad Med J       Date:  1983-01       Impact factor: 2.401

3.  How many blows really make an FEV1, FVC, or PEFR?

Authors:  M I Ullah; V Cuddihy; K B Saunders; G J Addis
Journal:  Thorax       Date:  1983-02       Impact factor: 9.139

4.  Ipratropium bromide: are patients treated with optimal therapy?

Authors:  A B Millar; A Bush; H al-Hillawi; J Goldman; D M Denison
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

5.  Bronchial responsiveness to hyperventilation in children with asthma: inhibition by ipratropium bromide.

Authors:  N Wilson; C Dixon; M Silverman
Journal:  Thorax       Date:  1984-08       Impact factor: 9.139

Review 6.  Anticholinergic agents for chronic asthma in adults.

Authors:  M Westby; M Benson; P Gibson
Journal:  Cochrane Database Syst Rev       Date:  2004

7.  Ipratropium bromide in patients with nocturnal asthma.

Authors:  I D Cox; D T Hughes; K A McDonnell
Journal:  Postgrad Med J       Date:  1984-08       Impact factor: 2.401

Review 8.  Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis.

Authors:  G E Pakes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

9.  Dose-response comparison of ipratropium bromide from a metered-dose inhaler and by jet nebulisation.

Authors:  S A Gomm; N P Keaney; L P Hunt; S C Allen; T B Stretton
Journal:  Thorax       Date:  1983-04       Impact factor: 9.139

10.  The influence of ipratropium bromide and sodium cromoglycate on benzalkonium chloride-induced bronchoconstriction in asthma.

Authors:  K A Miszkiel; R Beasley; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.